When internalized receptors and other cargo are destined for lysosomal degradation, they are ubiquitinated and sorted by the endosomal sorting complex required for transport (ESCRT) complexes 0, I, II and III into multivesicular bodies. Multivesicular bodies are formed when cargo-rich patches of the limiting membrane of endosomes bud inwards by an unknown mechanism and are then cleaved to yield cargo-bearing intralumenal vesicles. The biogenesis of multivesicular bodies was reconstituted and visualized using giant unilamellar vesicles, fluorescent ESCRT-0, -I, -II and -III complexes, and a membrane-tethered fluorescent ubiquitin fusion as a model cargo. Here we show that ESCRT-0 forms domains of clustered cargo but does not deform membranes. ESCRT-I and ESCRT-II in combination deform the membrane into buds, in which cargo is confined. ESCRT-I and ESCRT-II localize to the bud necks, and recruit ESCRT-0-ubiquitin domains to the buds. ESCRT-III subunits localize to the bud neck and efficiently cleave the buds to form intralumenal vesicles. Intralumenal vesicles produced in this reaction contain the model cargo but are devoid of ESCRTs. The observations explain how the ESCRTs direct membrane budding and scission from the cytoplasmic side of the bud without being consumed in the reaction.
It was shown 30 years ago that after stimulation, internalized EGF receptor localized to multivesicular bodies (MVBs) of human cells within minutes 1 . MVBs subsequently fuse with lysosomes where their contents are degraded 2, 3 . Downregulation of cell surface receptors and transporters in yeast occurs by the same pathway, and yeast genetics identified the machinery responsible, now known as the ESCRT complexes [4] [5] [6] [7] . The ESCRTs also function in membrane remodelling reactions in the budding of human immunodeficiency virus 1 (HIV-1) and other enveloped viruses from the plasma membrane [8] [9] [10] , and in the cleavage of the membrane neck between dividing cells in humans 11, 12 and a subset of archaea 13 . The ESCRT-III complex is required for MVB biogenesis, viral budding and cytokinesis, and is responsible for the membrane cleavage step in the detachment of membrane buds into the lumen of the MVB 14 . Ubiquitination is the principal signal for cargo to be directed into the MVB pathway. The upstream complexes ESCRT-0, -I and -II contain ubiquitin (Ub)-binding domains (UBDs) that are responsible for interactions with ubiquitinated cargo 15, 16 .
ESCRT-III proteins are capable of forming tubular structures [17] [18] [19] , membrane evaginations 20 , and budded intralumenal vesicles (ILVs) 14 in vitro or when overexpressed in cells. Most current thinking about the origin of membrane buds in MVBs has centred on the role of the ESCRT-III proteins 21 . The attraction of these models is that ESCRT-III-induced buds have been directly observed in overexpression systems and in vitro. A major drawback to these models is that there is no satisfactory explanation of how ESCRT-III proteins can be rescued and recycled from self-induced buds. ESCRT-mediated membrane budding has been difficult to analyse in cells because deletion or knockdown of any of the essential ESCRT genes, whether upstream or downstream, leads to the formation of the aberrant class E compartment 7, 22 . By electron microscopy, the class E compartment induced by deletion of subunits of ESCRT-0, -I, -II and -III consists of stacked cisternae that are devoid of ILVs [23] [24] [25] (G. Odorizzi, personal communication). These difficulties in resolving the mechanism of MVB biogenesis in vivo motivated us and others to reconstitute the pathway for analysis in vitro 14, 26, 27 . Using reconstitution in giant unilamellar vesicles (GUVs), we now show that ESCRT-I and -II together induce buds by stabilizing the bud neck. They recruit the ESCRT-III subunits Vps20 and Snf7 to the neck, but not the lumen, of the bud, such that the bud can be cleaved from the exterior end of the neck with no loss of ESCRT complexes to the interior. Furthermore, we find that ESCRT-0 forms large clusters of Ub on the membrane surface that are recruited to the bud necks by the ESCRT-I-ESCRT-II supercomplex. These observations provide the basis for a molecular mechanism of MVB biogenesis and cargo sorting that is fully consistent with biological observations.
Cargo clustering by ESCRT-0
Because the upstream ESCRT complexes contain UBDs, we wished to investigate whether they clustered ubiquitinated cargo, by analogy to other coat and adaptor systems in trafficking. To create a model system for endosomal cargo sorting, the carboxy terminus of Ub was fused to green fluorescent protein (GFP) or cyan fluorescent protein (CFP), and was tethered by an amino-terminal polyhistidine tag to GUVs incorporating the Ni 21 -chelating lipid Ni-NTA-DOGS ( Fig. 1a ). Labelled yeast (Saccharomyces cerevisiae) ESCRT-0 was found to co-localize with Ub in patches of up to 5 mm across (Fig. 1a ). The increase in fluorescence of the rhodamine-PE membrane marker is due to clustering of the acidic dye with the basic tag on the cargo, as this effect is not seen when the uncharged membrane reporter BODIPY-PC is used ( Supplementary Fig. 1 ). The ability of ESCRT-0 to cluster Ub is consistent with its pentavalent Ub binding through three ubiquitin-interacting motifs (UIMs) and two VHS (Vps27, Hrs and STAM) domains [28] [29] [30] [31] [32] [33] . Ub clustering is abrogated by the Ub mutation I44D (Fig. 1b) , which disrupts the interaction with the UBDs of ESCRT-0 (refs 34, 35) . This shows that Ub clustering is mediated by the direct interaction between Ub and the UBDs of ESCRT-0.
ESCRT-0 clustered on the membrane in domains in which the size and number were enhanced by, but not completely dependent on, binding to Ub (Fig. 1c ). This indicates that ESCRT-0 has an intrinsic ability to cluster on membranes. On the other hand, the clustering of Ub itself depends absolutely on the integrity of the Ub Ile 44 patch ( Fig. 1d ), consistent with the direct role of the ESCRT-0 UBDs. The ESCRT-0 subunit Hrs contains a clathrin-binding motif 36 and localizes to extended, flat clathrin coats on endosomes 37 . Our observations suggest that lateral self-organization is an intrinsic property of ESCRT-0, although it might be augmented or stabilized in the presence of clathrin. In contrast, isolated yeast ESCRT-I or -II, which have two and one known UBDs, respectively 4, 15, 16, 38, 39 , do not cluster Ub by themselves ( Supplementary Fig. 2a , b), although as described later, the combination of the two together sometimes manifested small punctate Ub clusters. We infer from these data that ESCRT-0 is the main driving force for cargo clustering in the pathway.
ESCRT-I and -II induce bud formation and confine cargo
A central motivation for this study was to discover how the limiting membrane buds into MVBs. The addition of 15 nM each of ESCRT-I and -II together evaginated the membrane into numerous cargocontaining buds ( Fig. 2a, b ), although no single ESCRT complex generated buds by itself (Figs 1a, 2c and Supplementary Fig. 2 ). The lumens of the GUVs were devoid of ILVs. The presence or absence of the upstream ESCRT-0 complex or the downstream ESCRT-III protein Vps20 did not markedly alter the number or character of buds formed ( Fig. 2c and Supplementary Fig. 3 ), indicating that budding is a distinct activity of the ESCRT-I and -II pair. The presence of cargo was not required for budding mediated by ESCRT-I and -II ( Supplementary Fig. 4 ). In contrast to ESCRT-I and -II, which induce buds even at concentrations below their estimated levels in yeast cells (Supplementary Table1), physiological concentrations of ESCRT-III subunits do not produce buds ( Fig. 2c and Supplementary Fig. 5 ). We attribute our previous observation of ESCRT-III-induced buds 14 to the presence of up to 40-fold higher subunit concentrations than those used in this study.
The affinities of isolated ESCRT UBDs for Ub are in the range of dissociation constant (K d ) 5 200 mM or lower, yet physiological ESCRT substrates are thought to typically be present in nM concentrations. Using 65 nM Ub-GFP, we assessed the ability of the upstream yeast ESCRTs to reduce the mobility of membrane-tethered Ub by fluorescence recovery after photobleaching (FRAP) microscopy. Ub-GFP in the limiting membrane quickly recovered after photobleaching ( Supplementary Fig. 6 ). Exchange with Ub-GFP in bulk solution occurs under these experimental conditions, as a GUV photobleached in its entirety was still able to recover. About half of the cargo within ESCRT-0 Ub domains underwent exchange ( Fig. 2d, e ). The presence of ESCRT-I and -II slowed the exchange of the mobile fraction by a factor of three, but did not alter the proportion of cargo capable of exchange. Cargo within the buds did not recover detectable fluorescence on the timescale of the experiment, regardless of the presence of ESCRT-0 ( Fig. 2d , e and Supplementary  Fig. 6 ). Therefore, cargo is confined within the buds. The bud necks are still open to exchange with bulk solution ( Supplementary Fig. 7 , rows 2-4), so closure of the neck is not responsible for cargo confinement. These results indicate the cargo in the buds does not efficiently exchange either through lateral diffusion in the membrane or through the soluble phase.
ESCRT-I and -II localize to the necks of membrane buds ESCRT-I and ESCRT-II were diffusely localized in the absence of other ESCRTs ( Fig. 2a, b) , with ESCRT-I sporadically visible in concentrations at bud necks (data not shown). The addition of Vps20the ESCRT-II-binding subunit of ESCRT-III-strongly enhanced the localization of ESCRT-I and -II at membrane buds without noticeably affecting the number or size of the buds. In the presence of Vps20, ESCRT-I ( Fig. 3a ) and ESCRT-II ( Fig. 3b ) were clearly visualized at membrane necks. No concentrations of ESCRT-I or -II could be seen within the evaginated membrane buds. Tethered Ub was present within the evaginations and clustered in bright punctate structures at the neck connecting the evagination to the limiting membrane. The puncta of ESCRT-I and -II co-localized with the bright puncta of Ub. The main conclusion derived from this experiment is that physiologically low nM amounts of ESCRT-I and -II produce extensive budding of membrane into the GUV lumen, without themselves entering the lumen. Instead, ESCRT-I and -II localize to the neck of the bud, suggesting that they produce buds by inducing and stabilizing the bud necks.
Coordination of Ub-clustering and bud formation
Having found that the upstream ESCRTs collectively carried out the key functions of Ub-cargo clustering and membrane budding, we sought to determine how these functions were coordinated. Labelled ESCRT-0 and Ub-CFP were monitored in the context of unlabelled ESCRT-I and -II. ESCRT-I and -II produced membrane buds, as seen also in the absence of ESCRT-0. The size and number of membrane buds did not change markedly from those generated in the absence of ESCRT-0 ( Fig. 2c) . The size and number of ESCRT-0-Ub domains also did not change markedly after ESCRT-I and -II addition (Fig. 1b) . Most ESCRT-0-Ub domains were found co-localized with membrane buds (Fig. 4a ). The co-localization of both buds with clusters and clusters with buds was sharply reduced in a mutant ESCRT-0 (DP(S/T)XP) 40, 41 that blocked the interaction between ESCRT-0 and ESCRT-I (Fig. 4b, c ). There were fewer ESCRT-0-Ub domains observed than membrane buds, probably because each ESCRT-0 domain involves more complexes than each membrane bud. Only 50% of membrane buds were associated with ESCRT-0 domains (Fig. 4c) , consistent with the greater number of buds. However, 80% of the ESCRT-0 domains colocalized with at least one membrane bud (Fig. 4c ). This observation confirms that the division of labour apparent for the isolated complexes or binary combinations, in which ESCRT-0 clusters cargo whereas ESCRT-I and -II generate membrane buds, holds even when all three of the complexes are present simultaneously. 
ESCRT-I-ESCRT-II recruits ESCRT-III for scission
We previously reported that the ESCRT-III subunits Vps20, Snf7 and Vps24, added in that order, had the intrinsic ability to scaffold their own bud neck and then cleave them 14 . We sought to determine whether the necks of buds scaffolded by ESCRT-I and -II were competent to recruit ESCRT-III subunits, and if they supported ESCRT-III-mediated scission. The Vps20 subunit of ESCRT-III directly binds to and is activated by ESCRT-II on membranes 42, 43 . In the presence of Vps20, little or no membrane scission is observed, consistent with the absence of the ESCRT-III subunit Snf7, a critical scission factor (Fig. 5a ). Under the same conditions, except with unlabelled ESCRT-II, labelled Vps20 also localizes to bud necks. Labelled Vps20 is wholly absent from the membrane in the interior of the buds, and seems to be confined to the neck by its strong interaction with ESCRT-II. When labelled Snf7 is added to unlabelled ESCRT-0, -I, -II and Vps20, it is observed to colocalize with membrane necks and to be completely excluded from the interior membrane in the buds (Fig. 5b) . Moreover, numerous ILVs are seen in the lumen of the GUV, indicating that scission of the membrane necks is occurring ( Fig. 5c and Supplementary Fig. 7, row 5 ). This reaction occurs efficiently with only 15 nM of each component, whereas previous in vitro scission conditions lacking ESCRT-0 and -I required 13-fold more Snf7 in the presence of threefold more ESCRT-II 43 , or 40-fold more Snf7 in the absence of any upstream ESCRT complexes 14 . ILVs generated in this reaction contain Ub-CFP, but are completely devoid of Snf7. The slowed reaction allowed us to visualize what we believe to be intermediates in the scission reaction, where Snf7 is localized to the bud necks and is poised for, or in the process of, severing the necks. When the third subunit important for scission, Vps24, was added, scission was efficient. Essentially all of the ILVs were detached from the limiting membrane ( Supplementary Fig. 7 , row 6), as expected.
Discussion
The observations in this study reveal a clear-cut division of labour between the ESCRT complexes. ESCRT-0 is primarily responsible for cargo clustering, the ESCRT-I-ESCRT-II supercomplex for membrane budding and cargo sequestration in buds, and ESCRT-III for scission.
The ESCRT-0 subunit Hrs is a component of flat coats with clathrin on endosomes before their maturation into MVBs 37 . Such stiff, flat structures would seem to inhibit the formation of membrane buds. Having observed that ESCRT-I and -II membrane buds are associated with the edge of ESCRT-0-Ub domains in vitro, it now seems likely that in cells, buds form at the edge of an extended clathrin-ESCRT-0 coat 16 . This suggests a model in which a large clathrin-ESCRT-0 domain could serve as a cargo reservoir for buds spawned at the domain boundary. The driving force for cargo migration from the ESCRT-0 domain into the bud in the cellular setting remains to be discovered.
The biggest surprise and insight is that membrane buds are generated by ESCRT-I and -II, not by ESCRT-III, contrary to widespread expectation. The membrane budding generated by high concentrations of ESCRT-III proteins is probably a by-product of the physics of any curved filament with a membrane binding capacity 44 . Rather, a supercomplex of ESCRT-I and ESCRT-II is responsible for membrane budding. The intimate cooperation of these two complexes, which act on the membrane as a single activity, is consistent with their high affinity for one another 45 , co-assembly on membranes 46 and co-operativity in Ub-cargo interactions 38 . ESCRT-I and -II are sufficient to sequester cargo in the buds, on the basis of FRAP analysis. It has been suggested that cargo is confined by a fence composed of ESCRT-III subunits 47 . The present observations suggest that although ESCRT-III may abet cargo sequestration by stabilizing the ESCRT-I-ESCRT-II bud neck assembly and cleaving ILVs, ESCRT-I and ESCRT-II are primarily responsible.
The lack of ESCRTs in the interior membrane of the buds shows that ESCRT-I and -II do not template buds by forming an interior coat. In other words, the ESCRTs do not act like 'inside-out' clathrin or COPII. The ILVs observed in this study are on the order of 2 mm in diameter, as compared to 25 nm for the largest molecular dimension of ESCRT-I, and mean diameters of 56 and 24 nm for human and yeast ILVs, respectively 25, 48 . The disparity between in vitro and in vivo ILV sizes, and the absence of interior-localized ESCRT-I and -II argues against the suggestion that ESCRT structures template ILV size 46 . Other factors, notably tension and bending modulus, need to be considered. ESCRT-I and ESCRT-II (particularly as complexed with Vps20) contain many points of contact with membranes that are separated from each other by rigid stalks on the order of 15 nm 43, 46, 49, 50 . These separations correspond to reasonable dimensions for a membrane neck.
In the reconstitution reported here, scission occurs with minimal or no internalization of ESCRTs. There have been no consistent reports of ESCRTs localized within MVBs, and all available evidence shows that to the contrary, ESCRTs are continuously recycled and used in several rounds of scission. When ILV budding and scission is driven in vitro by ESCRT-III alone, ESCRT-III was localized both within and outside ILVs, and the portion localized within was consumed in the reaction. In the presence of ESCRT-I and -II, ESCRT-III stays outside the bud, consistent with observations in cells. The unusual ability of ESCRT-III to cleave from outside the bud depends on its restricted localization to the neck. ESCRT-III has been visualized at midbodies connecting dividing cells 11, 12 , and ESCRT-III has been modelled as an interior collar capable of severing the neck from within 51 . Similarly, it has been widely expected that ESCRT-III would form a collar lining the inside of the neck of nascent HIV-1 virions where they attach to the plasma membrane of T-lymphocytes and macrophages 9, 10, 19 , and at the connection between the limiting membrane of the MVB and nascent ILVs 15, 21 . In this regard, it is satisfying to visualize ESCRT-III localization directly to the neck of budding ILVs. These observations are consistent with the concept that ESCRT-III severs nascent HIV-1 virions from the plasma membrane, and cuts membranous connections between dividing cells, through the same type of neck-constricting activity.
In summary, ubiquitinated cargo sorting into MVBs by the ESCRTs has been reconstituted using purified components in a reaction that mirrors the known biological properties of the pathway and violates none of them. ESCRT-0 forms large domains of clustered cargo, consistent with its polyvalent Ub binding and its known participation in flat clathrin coats in early endosomes, upstream of the rest of the ESCRT pathway (Fig. 6a ). ESCRT-I and -II, the molecular function of which has been ill-defined, are responsible for membrane budding into the lumen of the MVB (Fig. 6b ). ESCRT-I and -II seem to act by an unusual mechanism in which their rigid multivalent membrane-binding structures may template the formation of bud necks (Fig. 6c ). We propose that the large ESCRT-0-cargo domain acts as a cargo reservoir for a succession of smaller ESCRT-I-ESCRT-II buds until the cargo is all internalized and the coat disassembles. ESCRT-III has a highly restricted localization to the membrane neck and carries out scission efficiently even at low nanomolar concentrations ( Fig. 6d) , confirming the concept of ESCRT-III as a scission machine for membrane necks.
METHODS SUMMARY
Protein purification and labelling. The recombinant ESCRT-0 complex was expressed in yeast and purified using Ni-NTA affinity chromatography and gel filtration ( Supplementary Fig. 8 ). ESCRT-I, -II, Vps20, and Snf7 were expressed in bacteria and purified as previously described 14, 46, 50 . ESCRT-0, -I and -II were labelled with Alexa 488 on native Cys residues, and the engineered Vps20(Asn85Cys) and Snf7 N-terminal Cys were labelled on introduced Cys residues. In vitro MVB biogenesis reactions. GUVs were prepared essentially as described 14 with the addition of 5% (mol/mol) Ni-NTA-DOGS and a corresponding reduction in the mole fraction of POPC (1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine). A 200-ml observation chamber (Lab-Tek chambered 1.0 Borosilicate) was coated using 5 mg ml 21 BSA to avoid distortion of GUVs on contact with the bottom of the chamber, and rinsed with buffer (50 mM Tris-HCl, pH 7.4, 300 mM NaCl). One-hundred microlitres of GUVs were incubated with 130 nM His 6 -GFP-Ub (for FRAP experiments) or His 6 -CFP-Ub (for all other experiments) for 15 min, mixed with 100 ml of the first ESCRT complex to be added (15 nM final concentration), and incubated for 5 min. The buffer and all proteins added to GUVs matched the osmolarity of the GUV solution (,650 mosM due to evaporation of ,10% water during electroformation at 60 uC). The other ESCRT complexes or ESCRT-III subunits were added to the GUV-buffer mixture to yield a final concentration of 15 nM. The solution was stirred to accelerate protein distribution and binding. All steps of protein addition were separated by 5-min incubation intervals at room temperature. One buffer control was performed for each experiment. This control was treated exactly like that of the actual experiment; however, only buffer and no ESCRT proteins was added. Stirring and incubation was the same for control and experiment.
Full Methods and any associated references are available in the online version of the paper at www.nature.com/nature. II recruits Vps20 to the neck, which in turn recruits Snf7, the main engine for neck scission. d, After scission, cargo is internalized in ILVs while ESCRT-III remains on the outside of the limiting membrane until it is recycled by Vps4.
METHODS
Lipids and dyes. The following lipids were purchased from Avanti Polar Lipids: 1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-L-serine (POPS), 1-palmitoyl-2oleoyl-sn-glycero-3-phosphocholine (POPC), cholesterol, 1,2-dioleoyl-snglycero-3-[(N-(5-amino-1-carboxypentyl)iminodiacetic acid)succinyl] (nickel salt; Ni-NTA-DOGS), 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-(lissamine rhodamine B sulphonyl) (rhodamine-PE). Phosphatidylinositol 3-phosphate diC16 (PI(3)P) was purchased from Echelon. Thiol-reactive Alexa (Alexa Fluor 488 C5 maleimide) and BODIPY-FL-C5-HPC were from Molecular Probes. Cloning, expression and purification of proteins. DNA encoding ESCRT-0 subunits Hse1 and Vps27 was amplified by PCR from Saccharomyces cerevisiae genomic DNA and cloned into the pESC-Ura yeast expression vector (Stratagene). Hse1 was expressed fused to an N-terminal His 6 -tag followed by a TEV protease cleavage site. The construct was transformed into the protease deficient yeast strain DDY1810 (a gift from B. Wendland). The yeast culture was grown to an A 600 nm of 0.8 in YNB supplemented with 2% (w/w) raffinose, 20 mg l 21 tryptophan and 30 mg l 21 leucine at 30 uC. The expression of ESCRT-0 was induced by the addition of 2% (w/w) galactose, 20 g l 21 yeast extract, and 15 g l 21 bacto tryptone. The complex was expressed at 28 uC for 16 h and purified using Ni-NTA resin (Qiagen) and eluted with 100 mM imidazole. Elution fractions were cleaved using TEV protease and further purified by gel filtration (Superdex 200 column) and a second affinity step (Ni-NTA resin). Pooled fractions of ESCRT-0 were concentrated to 7 mM, flash-frozen in liquid nitrogen and stored at 280 uC until use. The three PSDP-like motifs in Vps27 were mutated to AAAA (positions 427-430, 504-507 and 561-564) using the QuickChange Multi site directed mutagenesis kit (Stratagene), and the mutant ESCRT-0 complex was purified as described for the wild-type protein. The His 6 -Ub-GFP and -CFP fusion proteins used in this study were a gift from E. Boura.
Full-length yeast ESCRT-I and -II, subcloned into the pST39 vector, were transformed into Rosetta pLys cells and grown in LB (Luria Bertani) medium at 37 uC until an A 600 nm of 0.8 was reached. Expression was induced by addition of 0.5 mM isopropyl-b-D-thiogalactoside (IPTG) at 18 uC and the cultures were grown for a further 16 h. The complexes were purified by Ni-NTA affinity chromatography (His 6 -tag fused to Vps23 of ESCRT-I and Vps22 of ESCRT-II), and the tags were removed by digesting elution fractions with TEV protease. The complexes were further purified using size-exclusion chromatography (Superdex 200 16/60 columns, GE Healthcare), with 50 mM Tris, pH 7.4, and 300 mM NaCl as running buffer. Aliquots of all purified proteins were immediately flash-frozen in liquid nitrogen and stored at 280 uC. The ESCRT-III subunits Vps20 and Snf7 were cloned into the pHis2 vector, containing MBP in between the His-tag and the TEV cleavage site. Cultures were grown at 37 uC until an optical density at 600 nm of 0.8, induced with 0.5 mM IPTG and incubated at 30 uC for 3 h. The MBP-fusion proteins were purified using Ni-NTA affinity chromatography, and elution fractions were cleaved with TEV protease for 2 h at room temperature. The digested fractions were subjected to size-exclusion chromatography and further purified using a second affinity purification to remove traces of uncleaved protein and TEV protease. Snf7 was maintained at concentrations of ,8 mM and immediately flash-frozen in liquid nitrogen. Vps20 was concentrated to 20 mM, frozen in liquid nitrogen and stored at 280 uC until use.
The His 6 -Ub-GFP and -CFP fusion proteins used in this study were a gift from E. Boura. The I44D mutation was introduced using the QuickChange site directed mutagenesis kit (Stratagene), and the mutant was expressed and purified as described for the ESCRT-I and -II complexes. Fluorescent labelling of proteins. To label Vps20 and Snf7, a cysteine residue was introduced by mutating Asn 85 (Vps20) or inserted at the N terminus immediately after the start codon (Snf7) using the QuickChange Mutagenesis Kit (Stratagene) according to the manufacturer's protocol. ESCRT-0, -I and -II were labelled using their native Cys residues. The purified and concentrated proteins were labelled by incubating Alexa Fluor 488 C5 maleimide at a molar ratio of 1:1 with the protein at 30 uC for 1 h under a N 2 atmosphere. The labelled fraction was determined by running samples on an SDS-polyacrylamide gel and fluorescence scans of the gel in a Typhoon variable mode imager (GE Healthcare) using 488 nm excitation and 495 nm detection wavelengths. Quantification of labelling efficiency was achieved by separating excess of dye from labelled protein using two consecutive HiTrap Desalting Columns (GE Healthcare). Molar protein and Alexa 488 concentrations of the purified protein were determined using absorption at 280 and 495 nm, respectively. Labelling efficiencies for all reactions exceeded 90%. Preparation of GUVs. A thin film of lipid mixtures containing POPC (57 mol%), POPS (10 mol%), cholesterol (25 mol%), PI(3)P (3 mol%), Ni-NTA-DOGS (5 mol%) and lissamine-rhodamine-PE (0.1 mol%) was applied to glass slides covered with indium-tin oxide and placed into a self-made Teflon chamber. The glass slides were separated by a 2-mm thin sucrose solution (600 mM), and an AC electric field (1 V, 10 Hz) was applied for 4 h at 60 uC following the previously described GUV electroformation protocol 52 . The GUVs were collected after cooling down to room temperature and used immediately. In vitro MVB biogenesis reactions. GUVs were prepared essentially as described 14 with the addition of 5% (mol/mol) Ni-NTA-DOGS and a corresponding reduction in the mole fraction of POPC. A 200-ml observation chamber (Lab-Tek chambered 1.0 Borosilicate) was coated using 5 mg ml 21 BSA to avoid distortion of GUVs on contact with the bottom of the chamber and rinsed with buffer (50 mM Tris-HCl, pH 7.4, 300 mM NaCl). GUVs (100 ml) were incubated with 130 nM His 6 -GFP-Ub (for FRAP experiments) or His 6 -CFP-Ub (for all other experiments) for 15 min, mixed with 100 ml of the first ESCRT complex to be added (15 nM final concentration), and incubated for 5 min. The buffer and all proteins added to GUVs matched the osmolarity of the GUV solution (,650 mosM owing to evaporation of ,10% water during electroformation at 60 uC). The other ESCRT complexes or ESCRT-III subunits were added to the GUV-buffer mixture to yield a final concentration of 15 nM. The solution was stirred to accelerate protein distribution and binding. All steps of protein addition were separated by 5-min incubation intervals at room temperature. One buffer control was performed for each experiment. This control was treated exactly like that of the actual experiment; however, only buffer and no ESCRT proteins was added. Stirring and incubation was the same for control and experiment. Randomly chosen fields of view were evaluated to determine the number of membrane buds and ILVs per GUV. Reactions were performed as described earlier and all GUVs in the particular fields of view were scanned in the z direction. All membrane buds or ILVs per GUV were counted, and for each experimental condition 80-100 GUVs were analysed, except for results in Fig. 4c , which were based on 70-80 GUVs per experiment. Results were summarized in histograms. Histograms in figures show results from a single experiment. All experiments were repeated in triplicate yielding essentially identical numbers of buds and ILVs in each replicate. Confocal fluorescence microscopy. Images were taken in multi-tracking mode on a Zeiss LSM510 or Confocor laser-scanning confocal microscope with a 633 Plan Apochromat 1.4 NA objective and a 488/543 or 458 dichroic mirror at a resolution of 512 3 512 pixel. The GFP/Alexa 488 dyes or CFP were excited using the 488 nm or 458 nm line and rhodamine was excited with a 543 nm HeNe laser. GFP/Alexa 488 emission was collected with a 505-530 nm bandpass filter and CFP using a 470-500 nm bandpass filter. Rhodamine emission was collected with a 560 nm longpass filter. The pinholes for each channel were set for an approximate 1.5-2.5 mm optical slice. Laser power was 9 mW for the 543 nm channel and 24 mW for the 458 and 488 nm channels. Images were analysed using the LSM Examiner software. Fluorescence recovery after photobleaching. GUVs were incubated with His 6 -GFP-Ub and ESCRT complexes (as indicated in Fig. 2 and Supplementary Fig. 3 ) and as described earlier. Experiments were performed using a LSM510 laser scanning confocal microscope with a 633 Plan Apochromat 1.4 NA objective and a 488/543 dichroic mirror at a resolution of 124 3 124 pixel with threefold zoom and an open pinhole. GFP was excited using the 488 nm laser line and 14 mW for imaging before and after bleaching. GFP fluorescence was bleached using 100% laser power of the 458 nm, 488 nm and 514 nm laser lines for 20 iterations. Recovery was observed by scanning at 488 nm every 149 ms for at least 50 s. Fluorescence intensities were determined using the LSM Examiner software. For the analysis shown in Fig. 2 , ten FRAP curves of ten buds or clusters, respectively, from ten different GUVs were used. Chem. Soc. 81, 303-311 (1986).
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